Abstract:Background: Type 2 diabetes mellitus (T2DM) is a risk factor for acute myocardial infarction (AMI) and a common comorbidity in patients with AMI. T2DM doubles the fatality rate of patients with AMI in the acute phase of AMI and the follow-up period. However, the mechanisms by which T2DM increases the fatality rate remain unknown. This study sought to investigate changes in the gut microbiota of patients with AMI and T2DM (AMIDM) to extend understandings of the relative mechanisms from the aspects of gut microbiota. Methods: Patients were recruited and divided into 2 groups comprising 15 patients with AMIDM and 15 patients with AMI but without T2DM (AMINDM). Their stool samples and clinical information were collected. 16S ribosomal DNA sequencing was used to analyze the structure and composition of the gut microbiota based on the operational taxonomic units. Results: A significant difference was observed in the gut microbiota β diversity between the 2 groups. At the phylum level, the AMIDM patients showed an increase in the abundance of Firmicutes and a decrease in the abundance of Bacteroidetes compared to the AMINDM patients. At the genus level, the AMIDM patients showed an increase in the abundance of Companilactobacillus, Defluvitaleaceae UCG-011 and UCG-009, and a decrease in the abundance of Phascolarctobacterium and CAG 56 compared to the AMINDM patients. At the species level, the AMIDM patients showed an increase in the abundance of species unclassified NK4A214 group, Bacteroides clarus, Coprococcus comes, unclassified Defluviltaleaceae UCG-011, uncultured rumen bacterium, unclassified CAG 56, Barnesiella intestinihominis, Lachnospiraceae bacterium, Bacteroides nordii, unclassified UCG-009, and the Family XIII AD3011 group compared to the AMINDM patients. The gut microbiota function predictions indicated that the nucleotide metabolism-related pathway was significantly more increase in the patients with AMIDM than those with AMINDM. Additionally, the patients with AMIDM showed an increase in gram-positive bacteria and a decrease in the proportion of gram-negative bacteria. Our correlation analysis results on the gut microbiota and clinical parameters might extend understandings of the progression of AMI. Conclusions: Changes in the gut microbiota composition of patients with AMIDM affect the severity of the metabolic disturbance and may be responsible for poorer clinical outcomes and worse disease progression in patients with AMIDM compared to those with AMINDM.

Intestinal Microbial Metabolites Are Linked to Severity of Myocardial Infarction in Rats

Cecal Gut Microbiota and Metabolites Might Contribute to the Severity of Acute Myocardial Ischemia by Impacting the Intestinal Permeability, Oxidative Stress, and Energy Metabolism

Gut-dependent Microbial Translocation Induces Inflammation and Cardiovascular Events after ST-elevation Myocardial Infarction

Abstract 148: Gut Microbial Metabolites Modulate Immune Response for Cardiac Repair

Loss of Gut Microbiota Alters Immune System Composition and Cripples Postinfarction Cardiac Repair

Analysis of gut microbiota in patients with acute myocardial infarction by 16S rRNA sequencing

Atlas of gut microbe-derived products from aromatic amino acids and risk of cardiovascular morbidity and mortality

The Changes of Gut Microbiota after Acute Myocardial Infarction in Rats

Roles of oral and gut microbiota in acute myocardial infarction

High fiber diet attenuate the inflammation and adverse remodeling of myocardial infarction via modulation of gut microbiota and metabolites

The gut microbiotas with metabolites regulate the protective role of miR-30a-5p in myocardial infarction

Dysbiosis of Gut Microbiota in Patients With Acute Myocardial Infarction

Unveiling the microbiota-metabolite-myocardium axis: a novel perspective on cardiovascular health

The gut microbiome and microbial metabolites in acute myocardial infarction

The Effect of Probiotic Strains on Myocardial Infarction Size, Biochemical and Immunological Parameters in Rats with Systemic Inflammatory Response Syndrome and Polymorbidity

Microbial-derived imidazole propionate links the heart failure-associated microbiome alterations to disease severity

Microbial modulation of cardiovascular disease

Distinct Commensal Bacterial Signature in the Gut Is Associated With Acute and Long-Term Protection From Ischemic Stroke

Compositional alterations of the gut microbiota in acute myocardial infarction patients with type 2 diabetes mellitus

Long-term modification of gut microbiota by broad-spectrum antibiotics improves stroke outcome in rats

L-valine derived from the gut microbiota protects sepsis-induced intestinal injury and negatively correlates with the severity of sepsis